Remove Cost Control Remove Government Remove Pharmaceuticals Remove Research
article thumbnail

How To Overcome Three Challenges Facing Biotech Companies In 2021

Velocity Global

The COVID-19 pandemic highlighted the value of innovative medical solutions, leading to new opportunities for research, product approval, and funding. . Challenge 1: Maximizing Cost-Effectiveness . Funding research to fight health threats like COVID-19, cancer, and Alzheimer’s is expensive. regulations in 2021 and beyond.